Stocks in news: Angel Broking, RIL, TCS, NMDC, Dr Reddy's
Stocks to watch today on October 5: Angel Broking, RIL, TCS, NMDC, Dr Reddy's among others are the top stocks to watch out for in Monday's trading session
- Oct 5, 2020,
- Updated Oct 5, 2020 9:15 AM IST
Stocks to watch today: Here is a list of top stocks that are likely to be in focus in Monday's trading session based on latest developments. Investors are also awaiting April-June quarter earnings that are scheduled to be released today.
Angel Broking: Shares of Angel Broking which recently concluded its Rs 600-crore initial public offer will list on the bourses on Monday.
Reliance Industries: Company announced that Mubadala Investment, the Abu Dhabi-based sovereign investor company will invest Rs 6,247.5 crore into its subsidiary Reliance Retail Ventures.
TCS: The company will consider share buyback on October 7 along with Q2 earnings.
NMDC: The September production came in at 1.83 MT v/s 1.64 MT, while sales were at 2.11 MT v/s 1.91 MT.
Federal Bank: The lender's deposits rose 12.3% YoY to Rs 1,56,747 crore in September.
Laurus Labs: The pharma company announced the merger of two foreign subsidiaries of the company.
Panacea Biotec: The US Food and Drug Administration (USFDA) has issued a warning letter to Panacea Biotec for violating current good manufacturing practice norms at its Baddi plant in Himachal Pradesh.
Dr Reddy's Labs: The pharma company announced the launch of a generic version of Sapropterin Dihydrochloride Tablets for oral use in the US market.
Cadila Healthcare: Drug firm Zydus Healthcare on Sunday said it has launched generic anti-diabetic Dapagliflozin tablets across the country under the brand name 'Dapaglyn'
Havells: The company has decided to shift its switchgears production capacity from Guwahati location to its existing facilities at Baddi location.
PNC Infratech: The company has received a Letter of Award (LoA) for the project 'Construction of Haraulipur for 10 years' for a value of Rs 289.83 crore.
Future Enterprises: CARE downgraded rating on NCD issue to 'D' on account of default in payment of NCD interest.
Route Mobile: The company completed the acquisition of primarily intellectual property (software) and associated identified customer contracts (business) of TeleDNA Communications.
Stocks to watch today: Here is a list of top stocks that are likely to be in focus in Monday's trading session based on latest developments. Investors are also awaiting April-June quarter earnings that are scheduled to be released today.
Angel Broking: Shares of Angel Broking which recently concluded its Rs 600-crore initial public offer will list on the bourses on Monday.
Reliance Industries: Company announced that Mubadala Investment, the Abu Dhabi-based sovereign investor company will invest Rs 6,247.5 crore into its subsidiary Reliance Retail Ventures.
TCS: The company will consider share buyback on October 7 along with Q2 earnings.
NMDC: The September production came in at 1.83 MT v/s 1.64 MT, while sales were at 2.11 MT v/s 1.91 MT.
Federal Bank: The lender's deposits rose 12.3% YoY to Rs 1,56,747 crore in September.
Laurus Labs: The pharma company announced the merger of two foreign subsidiaries of the company.
Panacea Biotec: The US Food and Drug Administration (USFDA) has issued a warning letter to Panacea Biotec for violating current good manufacturing practice norms at its Baddi plant in Himachal Pradesh.
Dr Reddy's Labs: The pharma company announced the launch of a generic version of Sapropterin Dihydrochloride Tablets for oral use in the US market.
Cadila Healthcare: Drug firm Zydus Healthcare on Sunday said it has launched generic anti-diabetic Dapagliflozin tablets across the country under the brand name 'Dapaglyn'
Havells: The company has decided to shift its switchgears production capacity from Guwahati location to its existing facilities at Baddi location.
PNC Infratech: The company has received a Letter of Award (LoA) for the project 'Construction of Haraulipur for 10 years' for a value of Rs 289.83 crore.
Future Enterprises: CARE downgraded rating on NCD issue to 'D' on account of default in payment of NCD interest.
Route Mobile: The company completed the acquisition of primarily intellectual property (software) and associated identified customer contracts (business) of TeleDNA Communications.